Beta-blockade in heart failure: a comparison of carvedilol with metoprolol (Q28375958)

2

0 references

G Yip

3

0 references

L Y Yeung

4

0 references

K W Chan

5

0 references

K Raymond

6

0 references

K S Woo

Journal of the American College of Cardiology

7

0 references

language of work or name

English

0 references

publication date

1 November 1999

0 references

published in

0 references

volume

34

0 references

issue

5

0 references

page(s)

1522-8

0 references

cites work

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Beta-blocking agents in heart failure. Should they be used and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

1 reference

7 January 2021

A practical guide to assessment of ventricular diastolic function using Doppler echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Using exercise endpoints in heart failure trials: design considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Hemodynamic differences between metoprolol and carvedilol in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Right and left ventricular diastolic function in patients with and without heart failure: effect of age, sex, heart rate, and respiration on Doppler-derived measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

New Doppler echocardiographic applications for the study of diastolic function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Effect of beta-blockade on baroreceptor and autonomic function in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900367-8

7 January 2021

10.1016/S0735-1097(99)00367-8

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10551702

1 reference

Consolidated OpenCitations Corpus – April 2017